Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vanessa Previcini"'
Autor:
Annalisa Radeghieri, Silvia Alacqua, Andrea Zendrini, Vanessa Previcini, Francesca Todaro, Giuliana Martini, Doris Ricotta, Paolo Bergese
Publikováno v:
Journal of Extracellular Biology, Vol 1, Iss 9, Pp n/a-n/a (2022)
Abstract Antithrombin (AT) is a glycoprotein produced by the liver and a principal antagonist of active clotting proteases. A deficit in AT function leads to AT qualitative deficiency, challenging to diagnose. Here we report that active AT may travel
Externí odkaz:
https://doaj.org/article/42e189555db24a6f8b1e4fa2ec29118e
Autor:
Vanessa Previcini, Giuliana Martini, Paolo Bergese, Doris Ricotta, Silvia Alacqua, Annalisa Radeghieri, Andrea Zendrini, Francesca Todaro
Antithrombin (AT) is a glycoprotein produced by the liver and a principal antagonist of active clotting proteases. A deficit in AT function leads to AT qualitative deficiency, challenging to diagnose. Here we report that active AT may travel physioso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd230ef63d45cf7dfe2e98c638139549
https://hdl.handle.net/11379/565662
https://hdl.handle.net/11379/565662
Autor:
Luisa Imberti, Ruggero Capra, Simone Paghera, Chiara Cattaneo, Alessandra Sottini, Giuseppe Rossi, Luigi D. Notarangelo, Peter D. Burbelo, Kerry Dobbs, Elana Shaw, Eugenia Quiros-Roldan, Jeffrey I. Cohen, Vanessa Previcini
Publikováno v:
Blood
It has been proposed that patients with hematologic malignancy and autoimmune diseases receiving anti-CD20 monoclonal antibody (mAb) therapy are particularly at risk of severe Coronavirus disease (COVID-19) because the profound and long-lasting B-cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7c042cca73c95c199e1d97ea690c011
http://europepmc.org/articles/PMC8330377
http://europepmc.org/articles/PMC8330377
Publikováno v:
Drugsaging. 37(10)
Patients with multiple sclerosis exhibit the same qualitative and quantitative changes in immune system cells observed in aging. In the last 20 years, multiple sclerosis patients have shown an increase in life expectancy and average age, but clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33c305eedf71fd108c92e8b3c294c6b2
https://pubmed.ncbi.nlm.nih.gov/32761321
https://pubmed.ncbi.nlm.nih.gov/32761321